Sam Harris
Bendigo Health · 32 works · 1,375 citations · h-index 9
Top works
- Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
- Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers
- Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
- Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
- COVID‐19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study
- Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage II Colon Cancer (DYNAMIC Trial): Statistical Analysis Plan
- Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia
- 318MO Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC)
- Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
- Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation
- Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey
- COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
- Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial
- Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials
- Pharmacogenetic‐guided dosing for fluoropyrimidine ( DPYD ) and irinotecan ( UGT1A1*28 ) chemotherapies for patients with cancer ( PACIFIC ‐ PGx ): A multicenter clinical trial
- Teletrial implementation in early phase clinical trials: two national workshops
- Implementing Teletrials to Improve Equity of Access for Regional Patients With Cancer: Report From the Victorian Teletrial Collaborative
- Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia
- Poster Abstracts
- 882TiP Subcutaneous vs intravenous nivolumab in patients with melanoma following complete resection